Chondrosarcoma
Oncology·MeSH: Chondrosarcoma
Prevalence
5.0 / 100K
3 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Phase 2(2)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| inbrx-109 | Inhibrx Biosciences, Inc. (INBX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Chondrosarcoma?
BioSniper tracks 3 drugs in development for Chondrosarcoma across 2 companies.
How many clinical trials target Chondrosarcoma?
There are 5 clinical trials targeting Chondrosarcoma tracked by BioSniper.
What is the prevalence of Chondrosarcoma?
The estimated prevalence of Chondrosarcoma is approximately 5.0 per 100,000 population.
Deep-dive into Chondrosarcoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis